Research.Patient.info
Advanced or Metastatic Cancer research hub
2 indexed studies · 1 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
A Multicenter, Open-label, Phase 2 study of Intratumoral Vidutolimod (CMP-001) in Combination with Intravenous Cemiplimab in Subjects with Selected Types of Advanced or Metastatic Cancer
This study is testing a new combination of treatments for some advanced cancers. It involves two drugs, Vidutolimod and Cemiplimab, to see how well they shrink tumours. It's a Phase II study, meaning we're looking at how safe and effective this new approach might be.
France - recruitingPHASE2
Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
This study looks at a new drug called Cemiplimab for advanced skin cancer (basal cell carcinoma) that hasn't been treated before with certain other drugs. We want to see how well it works and if it's safe as a first treatment.
Germany